NBIX

Conviction 49HealthcareScan · Mon, Aug 10, 2026

NBIX$164.89+0.91%

ResistanceSupportVol 14Insider sellCongress buyCongress sell

Vol MA14 1.5M

May 11May 28Jun 16Jul 6Jul 23Aug 10

NEUROCRINE BIOSCIENCES INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.neurocrine.com ↗

Price164.89

Change+0.91%

Gap-0.24%

Rel volume0.78×

Avg volume1.35M

Avg $ vol232.44M

SMA 20171.77

SMA 50168.30

SMA 200146.64

Price vs 50-2.02%

Price vs 200+12.45%

MA stackmixed

50/200 cross—

Supertrenddown · 179.57

RSI (14)45

MACD hist-2.03

MACD crossbear · 6d

Stoch %K / %D23 / 15

ADX (14)27

+DI / −DI16 / 26

RSI divergence—

MACD divergence—

ATR %+3.53%

ADR %3.47%

52w high185.50

52w low123.10

From 52w high-11.11%

Above 52w low+33.95%

New 52w highNo

SqueezeOff

Bollinger width16.01%

%B0.25

Donchian pos23.20%

Donchian high186.12

Donchian low158.48

AVWAP (52w high)169.65

vs AVWAP high-2.80%

AVWAP (52w low)149.50

vs AVWAP low+10.30%

OBV trendFlat

Chaikin MF (20)-0.07

Today vs 20d0.78×

Avg vol (14d)1.5M

Avg vol (20d)1.35M

Avg $ vol (20d)232.44M

Market cap16.76B

RS 3m (vs SPY)+3.54%

RS 6m (vs SPY)+4.36%

RS line new highNo

Trend template5/8

Technical rank58.4

1 week-0.81%

1 month-6.90%

3 months+8.30%

6 months+16.78%

1 year+31.28%

YTD+17.28%

P/E35.02

P/B4.54

P/S5.86

P/FCF22.39

EPS4.67

Div yield—

ROE12.96%

ROA8.93%

Debt/Eq—

Current1.87

EV/EBITDA26.36

Gross margin—

Net margin16.73%

Rev growth21.45%

EPS growth40.23%

Price target211.28

Target upside28.13%

Analyst ratingBuy

Institutional111.81%

Ent. value16.43B

Revenue959M

Net income144.4M

Gross profit—

Free cash flow748.7M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out100.55M

Employees2K

ListedThu, May 23, 1996

Free float94.62M

Float %94.1%

Short interest5.33M

Days to cover4.9d

Short volume56.2%

Squeeze score47 / 100

Next earnings—

EPS forecast—

Last EPS vs est$2.36 vs $1.88

Last surprise+25.5% beat

Setup gradeC

Conviction49 / 100

Pattern quality—

Tech rank58.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance183.65

Support156.89

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 47 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jun 1 – Jun 26
4 scans
→
Breaking out now
Jul 28 – Jul 30
2 scans

Congress activity

Disclosed STOCK Act trades in NBIX · 2 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Lisa McClain house · R · MI · traded 2025-06-17	Sell	$1K–$15K	2025-06-17	2025-08-13	PDF
Lisa McClain house · R · MI · traded 2025-06-11	Buy	$1K–$15K	2025-06-11	2025-08-13	PDF

Insider activity

SEC Form 4 transactions in NBIX · 3 buys · 7 sells

Insider	Side	Shares	Value	Traded	Filed
Onyia Jude Chief Scientific Officer · Common Stock · 2026-08-04	Gift	2.41K	—	2026-08-04	2026-08-05
Delaet Ingrid Chief Regulatory Officer · Common Stock · 2026-07-10	Exercise	4.37K	$463K	2026-07-10	2026-07-13
Delaet Ingrid Chief Regulatory Officer · Common Stock · 2026-07-10	Sell	4.37K	$791K	2026-07-10	2026-07-13
Delaet Ingrid Chief Regulatory Officer · Non-Qualified Stock Option · 2026-07-10	Exercise	4.37K	—	2026-07-10	2026-07-13
Lippoldt Darin Chief Legal Officer · Common Stock · 2026-07-09	Exercise	10K	$815K	2026-07-09	2026-07-13
Lippoldt Darin Chief Legal Officer · Common Stock · 2026-07-09	Sell	10K	$1.8M	2026-07-09	2026-07-13
Lippoldt Darin Chief Legal Officer · Non-Qualified Stock Option · 2026-07-09	Exercise	10K	—	2026-07-09	2026-07-13
Delaet Ingrid Chief Regulatory Officer · Common Stock · 2026-07-09	Exercise	8.43K	$873K	2026-07-09	2026-07-09
Delaet Ingrid Chief Regulatory Officer · Common Stock · 2026-07-09	Sell	8.43K	$1.5M	2026-07-09	2026-07-09
Delaet Ingrid Chief Regulatory Officer · Non-Qualified Stock Option · 2026-07-09	Exercise	8.43K	—	2026-07-09	2026-07-09

SEC filings

EDGAR filings in NBIX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.